Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
EZRIP15311Ezrin (Cytovillin) (Villin-2) (p81)Cancer-related genesPlasma proteinsPredicted intracellular proteinsAdhesion and uptake mediationFusion and delivery mediationImmune mediation20.50
FZD4Q9ULV1Frizzled-4 (Fz-4) (hFz4) (FzE4) (CD antigen CD344)CD markersDisease related genesG-protein coupled receptors7Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
GABR1Q9UBS5Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)FDA approved drug targetsG-protein coupled receptorsPlasma proteins7Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.50
GAS2O43903Growth arrest-specific protein 2 (GAS-2)Predicted intracellular proteinsFusion and delivery mediation20.50
GLT12Q8IXK2Polypeptide N-acetylgalactosaminyltransferase 12 (EC 2.4.1.41) (Polypeptide GalNAc transferase 12) (GalNAc-T12) (pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12)Disease related genesEnzymesHuman disease related genes1Clinical-translation mediationMetabolism mediation20.50
GTR1P11166Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)Cancer-related genesDisease related genesHuman disease related genes12Skin diseaseClinical-translation mediationFusion and delivery mediationMetabolism mediation20.50
GUC1AP43080Guanylyl cyclase-activating protein 1 (GCAP 1) (Guanylate cyclase activator 1A)Disease related genesHuman disease related genesPredicted intracellular proteinsReceptor-signaling mediation20.50
ITA8P53708Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]Disease related genesHuman disease related genesPlasma proteins1Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation20.50
ITAXP20702Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)CD markersFDA approved drug targetsPredicted intracellular proteins1Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
KC1DP48730Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26)Disease related genesEnzymesHuman disease related genesMature B-cell leukaemiaPancreatic cancerClinical-translation mediationFusion and delivery mediationMetabolism mediation20.50
KISSRQ969F8KiSS-1 receptor (KiSS-1R) (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175) (hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor)Disease related genesG-protein coupled receptorsHuman disease related genes7Allergic/hypersensitivity disorderProstate cancerClinical-translation mediationReceptor-signaling mediation20.50
L1CAMP32004Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171)CD markersDisease related genesHuman disease related genes1Adrenal cancerBrain cancerAdhesion and uptake mediationClinical-translation mediationImmune mediation20.50
LAMP2P13473Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b)CD markersDisease related genesHuman disease related genes1Inborn carbohydrate metabolism errorClinical-translation mediationFusion and delivery mediationImmune mediation20.50
LIGO1Q96FE5Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A)Disease related genesHuman disease related genesPotential drug targets1Multiple sclerosisClinical-translation mediationReceptor-signaling mediation20.50
LPAR6P43657Lysophosphatidic acid receptor 6 (LPA receptor 6) (LPA-6) (Oleoyl-L-alpha-lysophosphatidic acid receptor) (P2Y purinoceptor 5) (P2Y5) (Purinergic receptor 5) (RB intron encoded G-protein coupled receptor)Disease related genesG-protein coupled receptorsHuman disease related genes7Receptor-signaling mediation20.50
LRP12Q9Y561Low-density lipoprotein receptor-related protein 12 (LDLR-related protein 12) (LRP-12) (Suppressor of tumorigenicity 7 protein)Disease related genesHuman disease related genesPredicted membrane proteins1Metabolism mediation20.50
MADDQ8WXG6MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (Rab3GEP)Disease related genesHuman disease related genesPredicted intracellular proteinsFusion and delivery mediationReceptor-signaling mediation20.50
MLIPQ5VWP3Muscular LMNA-interacting protein (Cardiac Isl1-interacting protein) (CIP) (Muscular-enriched A-type laminin-interacting protein)Disease related genesPredicted intracellular proteinsOther mediation20.50
MOESP26038Moesin (Membrane-organizing extension spike protein)Cancer-related genesDisease related genesHuman disease related genesAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
NF1P21359Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]Cancer-related genesDisease related genesHuman disease related genesAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
NLS1Q8NA29Sodium-dependent lysophosphatidylcholine symporter 1 (NLS1) (Sodium-dependent LPC symporter 1) (Major facilitator superfamily domain-containing protein 2A) (HsMFSD2A) (MFSD2a)Disease related genesHuman disease related genesPotential drug targets12Fusion and delivery mediationMetabolism mediation20.50
OPRKP41145Kappa-type opioid receptor (K-OR-1) (KOR-1)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Bipolar disorderChronic painCoronary vasospastic diseaseClinical-translation mediationFusion and delivery mediationImmune mediation20.50
PANX1Q96RD7Pannexin-1 (PANX1) [Cleaved into: Caspase-activated pannexin-1 (Caspase-activated PANX1)]Disease related genesHuman disease related genesPotential drug targets4Fusion and delivery mediationImmune mediation20.50
PARD3Q8TEW0Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha)Disease related genesPlasma proteinsPredicted intracellular proteinsClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.50
PIGNO95427GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (GPI-ethanolamine transferase I) (GPI-ETI) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N)Disease related genesHuman disease related genesMetabolic proteins15Metabolism mediation20.50